General Information
Revision date
2022-03-02
Product name
DYAZIDE CAPSULES
Product Synonyms
DYAZIDE CAPSULES 25 MG/37.5 MG * TRIAMTERENE AND HYDROCHLOROTHIAZIDE, FORMULATED PRODUCT
1.2.2. Uses advised against
No other uses are advised
Emergency telephone
VERISK 3E GLOBAL INCIDENT RESPONSE
Icons in SDS
Company Information
company name
GlaxoSmithKline Singapore Pharmaceuticals
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
GHS Information
Signal word
Warning
Section 2
Physical hazards
Not classified.
Health hazards
Specific target organ toxicity following single Category 3 respiratory tract irritation exposure
Environmental hazards
Not classified.
Signal word
Warning
Hazard statements
May cause respiratory irritation.
Prevention
Avoid breathing dust. Avoid breathing vapours. Use only outdoors or in a well-ventilated area.
Response
IF INHALED: Remove person to fresh air and keep comfortable for breathing. Call a POISON CENTRE/doctor if you feel unwell.
Storage
Store in a well-ventilated place. Keep container tightly closed. Store locked up.
Disposal
Dispose of contents/container in accordance with local/regional/national/international regulations.
Other hazards which do not result in classification
Caution - Pharmaceutical agent. See section 11 of the SDS for additional information on health hazards.
Additional information
7 % of the mixture consists of component(s) of unknown acute oral toxicity. 99 % of the mixture consists of component(s) of unknown acute dermal toxicity. 99 % of the mixture consists of component(s) of unknown acute inhalation toxicity. 99 % of the mixture consists of component(s) of unknown acute hazards to the aquatic environment. 99 % of the mixture consists of component(s) of unknown long-term hazards to the aquatic environment.
